AMGEN’S REPATHA® CUTS RISK OF FIRST MAJOR ADVERSE CARDIOVASCULAR EVENTS BY 25% IN LANDMARK PHASE 3 VESALIUS-CV TRIAL
THOUSAND OAKS, Calif., Nov. 8, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) [...]
ABC Hosts Three Signature Events at AHA25 in New Orleans on November 8
ABC Events at AHA 2025 – Saturday, November 8 [...]
ABC Wants to Spotlight You at AHA25 — Submit Your Session Info by Nov. 5
Are you chairing, moderating, presenting, or participating in a panel [...]
ABC Members Featured Among Faculty for the Masters of Medicine 2026 Conference in Jamaica
ABC Members Featured Among Faculty for the Masters of [...]
AstraZeneca launches direct-to-consumer platform to expand access to medications for US patients, including those living with chronic conditions
AstraZeneca today announces the launch of AstraZeneca Direct, an online [...]
BridgeBio to Present Additional Cardiovascular Outcomes Data from ATTRibute-CM at the HFSA Annual Scientific Meeting 2025
PALO ALTO, Calif., Sept. 22, 2025 (GLOBE NEWSWIRE) -- BridgeBio [...]
For the FITs | Navigating the Integration of AI in Cardiovascular Imaging
As cardiovascular medicine advances into the digital age, artificial intelligence [...]
American Heart Association Backs Auxira Health to Alleviate Cardiologist Burnout
The American Heart Association’s venture arm invested in Auxira Health, [...]
2025 ABC International Dr. Jay Brown Abstract Competition | June 28
The Association of Black Cardiologists (ABC), supported, in part, by Amgen [...]
Amgen Announces Robust Weight Loss With Maritide In People Living With Obesity Or Overweight At 52 Weeks In A Phase 2 Study
MariTide Demonstrated up to ~20% Average Weight Loss at 52 [...]